Entero Therapeutics, Inc. Quarterly Operating Lease, Liability, Noncurrent in USD from Q4 2018 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Summary
Entero Therapeutics, Inc. quarterly Operating Lease, Liability, Noncurrent history and growth rate from Q4 2018 to Q4 2024.
  • Entero Therapeutics, Inc. Operating Lease, Liability, Noncurrent for the quarter ending December 31, 2024 was $59K, a 59.8% decline year-over-year.
Operating Lease, Liability, Noncurrent, Quarterly (USD)
Operating Lease, Liability, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $59K -$87.9K -59.8% Dec 31, 2024 10-K/A 2025-04-09
Q3 2024 $80.2K -$85.8K -51.7% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $101K -$83.6K -45.3% Jun 30, 2024 10-Q 2024-10-21
Q1 2024 $128K -$68.9K -35.1% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $147K -$67.1K -31.4% Dec 31, 2023 10-K/A 2025-04-09
Q3 2023 $166K -$65.3K -28.2% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $185K -$63.6K -25.6% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $197K Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $214K -$97.1K -31.2% Dec 31, 2022 10-K 2024-03-29
Q3 2022 $231K -$64.4K -21.8% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $248K -$37.5K -13.1% Jun 30, 2022 10-Q 2022-08-15
Q4 2021 $311K +$292K +1527% Dec 31, 2021 10-K 2023-03-20
Q3 2021 $296K +$264K +840% Sep 30, 2021 10-Q/A 2021-11-16
Q2 2021 $286K +$242K +555% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $6.57K Mar 31, 2021 10-Q 2021-05-24
Q4 2020 $19.1K +$19.1K Dec 31, 2020 10-K 2022-03-31
Q3 2020 $31.5K -$1.21K -3.71% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 $43.6K -$788 -1.77% Jun 30, 2020 10-Q 2020-08-14
Q4 2019 $0 $0 Dec 31, 2019 10-K 2021-03-31
Q3 2019 $32.7K Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $44.4K Jun 30, 2019 10-Q 2019-08-13
Q1 2019 $93.4K Mar 31, 2019 10-Q 2019-05-15
Q4 2018 $0 Dec 31, 2018 10-Q 2019-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.